1. Which of the following disease-modifying therapies (DMTs) prevents lymphocyte migration into the central nervous system?

2. Which of the following DMTs does NOT have a Risk Evaluation and Mitigation Strategy (REMS) or medication guide associated with it?

3. Which of the following DMTs requires a first-dose observation period?

4. Compared with infused DMTs, self-injected DMTs are generally associated with:

« Return to Activity